Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rosemark is a private investment firm founded by entrepreneur Chris Burch, co-founder of Tory Burch, that specializes in growth-stage investments across the consumer, technology, and healthcare sectors. The firm employs a consumer-centric investment philosophy, backing companies that disrupt traditional industries through superior user experiences and brand innovation. In the healthcare and life sciences domain, Rosemark has made significant investments in prominent platforms such as Kindbody, a fertility and family-building benefits provider, and the genomics company 23andMe. Beyond providing capital, the firm offers strategic guidance in brand development, marketing, and operational scaling to its portfolio companies. Headquartered in New York, Rosemark operates as a flexible investment vehicle that leverages its founder's extensive experience in scaling global consumer brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rosemark Capital.